Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development

Br J Dermatol. 2016 Sep;175(3):636-8. doi: 10.1111/bjd.14622. Epub 2016 Jul 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biological Factors / therapeutic use*
  • Clinical Trials, Phase III as Topic / methods*
  • Dermatologic Agents / therapeutic use*
  • Drug Discovery
  • Drugs, Investigational / therapeutic use
  • Humans
  • Middle Aged
  • Patient Selection*
  • Psoriasis / drug therapy*
  • Young Adult

Substances

  • Biological Factors
  • Dermatologic Agents
  • Drugs, Investigational